Replies to post #221608 on Biotech Values

[jbog]

3Q18 worldwide Keytruda sales—>$1.89B, +89% YoY.

I would have thought they would be substantially higher than Optiva ($1.79B
+42%) at this point. I guess the growth rate will separate them shortly.